* Sector dogged by patent rows, price cuts, quality issues * Market leader Abbott, others still investing in India * GlaxoSmithKline spends $1... ...http://www.sify.com/finance/big-pharma-still-betting-on-messed-up-indian-drugs-market-news-crime-odmr0gaijbi.html
/PRNewswire/ -- Reportbuyer.com just published a new market research report: Report Details Alzheimer's medicine - your guide to technologies,... ...http://in.advfn.com/p.php?pid=nmona&article=61407964
/PRNewswire/ -- Antibacterials - new analysis showing business trends, R&D, and revenue forecasts What is the future of medicines treating... ...http://in.advfn.com/p.php?pid=nmona&article=61404385
Dasra launched a five-year, US$14mn initiative in collaboration with USAID and Kiawah Trust, which was announced at the Dasra Philanthropy Week... ...http://www.indiainfoline.com/Markets/News/Piramal-Foundation-joins-US-dollar-14mn-Dasra-Kiawah-Trust-USAID-Alliance/5882375037
I Launching a new drug in India, whether a completely new molecule or a generic one, has become a herculean task. The Supreme Court's recent... ...http://www.moneycontrol.com/news/cnbc-tv18-comments/delayclinical-trials-approval-affecting-pharma-sector_1050929.html
PIRAMAL HEALTH CARE .LTD
Urvi Ashok Piramal Foundation (UAPF)...